Clinical trial Recruiting at 1 site Observational Ages 18 to 60 Women only

Exploring the genetic factors of hearing loss in Turner Syndrome

Official title: Genetic and Epigenetic Background of Inner Ear Dysfunction in Turner Syndrome

Run by Gødstrup Hospital · NCT06507007 · Data updated 2026-11-12

This study is trying to find out how genetics might affect hearing loss in people with Turner Syndrome to help develop new treatments.

More Sensorineural Hearing Loss trials

Quick facts

Study typeObservational
Ages18 Years to 60 Years
SexWomen only
Enrollment150 (estimated)
SponsorGødstrup Hospital
Academic / other
Locations1 site (Herning)
StatusRecruiting
StartedFebruary 1, 2025
Main results expectedOctober 30, 2026
Study endsJuly 30, 2027
Registry record updatedSeptember 11, 2026
Trial IDNCT06507007 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are individuals aged 18 to 60 with Turner Syndrome who experience sensorineural hearing loss.

Probably not a fit

Patients with serious medical disorders, neurological or psychiatric conditions, or those taking medications affecting inner ear function may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to investigate the genetic and epigenetic factors associated with sensorineural hearing loss in individuals with Turner Syndrome. By examining DNA methylation patterns and RNA expression profiles, the study seeks to identify potential links between these genetic markers and inner ear dysfunction. Participants will undergo a series of tests, including ear examinations, hearing assessments, balance evaluations, blood tests, and imaging scans, to gather comprehensive data on their inner ear health. The ultimate goal is to uncover insights that could lead to innovative treatments for hearing loss.

Why it matters

Potential benefit: If successful, this study could lead to new treatment options that may reduce or eliminate the need for hearing aids in patients with Turner Syndrome.

How similar studies have gone: While the specific approach of this study is novel, previous research has indicated that exploring genetic and epigenetic factors can yield valuable insights into hearing loss.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* age between 18 and 60 years old

Exclusion Criteria:

* Contraindications for the MRI or CBCT
* Serious medical disorders
* Neurological or psychiatric disorders of any kind
* Use of medication that is known to influence inner ear function
* Medical history with dizziness or hearing problems (controls only)

Where it's running

  • ENT department of Gødstrup Hospital
    Herning, Denmark
    Recruiting

Study contacts

  • Principal investigator: Therese Ovesen, Prof — University Clinic of Flavour, Balance and Sleep
  • Study coordinator: Louise Hill-Madsen, MD
  • Email: lohill@rm.dk
  • Phone: 20282635

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.